Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
LOS ANGELES Pfizer on Friday identified seven finalists participating in reviews for creative chores on three of its drug brands previously handled by Interpublic Group’s Deutsch.
Vying for pain-reliever Bextra are Arnold, Berlin Cameron/Red Cell, McCann-Erickson, Publicis and TBWA\Chiat\Day.
Contending for the Zoloft anti-depressant brand are Arnold, Kaplan Thaler Group, Merkley Newman Harty & Partners’ MNH Healthworks and Publicis.
The contenders for allergy medicine Zyrtec are Berlin Cameron, Kaplan Thaler, MNH Healthworks and TBWA\C\D.
Client representative Susan Yarin confirmed the finalists and said the brands are worth $120 million combined.
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in